Insufficient scRNA-seq data for expression of CBX2 at single-cell level.
Insufficient scRNA-seq data for expression of CBX2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 97% | 268.97 | 165 / 170 | 90% | 24.10 | 411 / 459 |
skin | 100% | 379.52 | 1807 / 1809 | 81% | 14.24 | 383 / 472 |
ovary | 99% | 441.43 | 179 / 180 | 80% | 16.03 | 344 / 430 |
bladder | 100% | 212.14 | 21 / 21 | 73% | 14.42 | 369 / 504 |
esophagus | 96% | 407.03 | 1381 / 1445 | 74% | 15.64 | 135 / 183 |
breast | 97% | 276.34 | 446 / 459 | 65% | 15.99 | 724 / 1118 |
lung | 90% | 248.65 | 520 / 578 | 71% | 16.10 | 821 / 1155 |
intestine | 87% | 121.12 | 845 / 966 | 69% | 8.97 | 361 / 527 |
stomach | 76% | 96.42 | 272 / 359 | 65% | 8.92 | 185 / 286 |
brain | 59% | 54.85 | 1556 / 2642 | 61% | 6.92 | 431 / 705 |
prostate | 91% | 142.84 | 222 / 245 | 26% | 2.36 | 133 / 502 |
thymus | 91% | 133.25 | 597 / 653 | 22% | 2.57 | 134 / 605 |
pancreas | 95% | 163.92 | 311 / 328 | 16% | 2.99 | 29 / 178 |
spleen | 100% | 349.46 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 97% | 287.04 | 1172 / 1204 | 0% | 0 | 0 / 0 |
heart | 93% | 198.64 | 798 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 15.04 | 41 / 45 |
kidney | 78% | 135.48 | 69 / 89 | 6% | 0.51 | 54 / 901 |
adrenal gland | 58% | 62.19 | 149 / 258 | 10% | 1.17 | 24 / 230 |
lymph node | 0% | 0 | 0 / 0 | 62% | 4.66 | 18 / 29 |
liver | 36% | 39.95 | 81 / 226 | 21% | 2.23 | 85 / 406 |
eye | 0% | 0 | 0 / 0 | 48% | 3.42 | 38 / 80 |
blood vessel | 41% | 58.84 | 550 / 1335 | 0% | 0 | 0 / 0 |
muscle | 32% | 26.16 | 255 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 19% | 43.46 | 181 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_0045137 | Biological process | development of primary sexual characteristics |
GO_0030154 | Biological process | cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0031519 | Cellular component | PcG protein complex |
GO_0000792 | Cellular component | heterochromatin |
GO_0000791 | Cellular component | euchromatin |
GO_0035102 | Cellular component | PRC1 complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0035064 | Molecular function | methylated histone binding |
GO_0005515 | Molecular function | protein binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | CBX2 |
Protein name | Chromobox protein homolog 2 |
Synonyms | |
Description | FUNCTION: Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development . PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility . Binds to histone H3 trimethylated at 'Lys-9' (H3K9me3) or at 'Lys-27' (H3K27me3) (By similarity). Plays a role in the lineage differentiation of the germ layers in embryonic development (By similarity). Involved in sexual development, acting as activator of NR5A1 expression . . |
Accessions | Q14781 ENST00000310942.9 [Q14781-1] ENST00000269399.5 [Q14781-2] |